Trademarkia Logo

Canada

C$
MELAGENIX
REGISTERED

on 14 Jan 2021

Last Applicant/ Owned by

NERACARE GMBH

Eschenheimer Anlage 2660318 Frankfurt am Main

DE

Serial Number

1886605 filed on 7th Mar 2018

Registration Number

TMA1091622 registered on 14th Jan 2021

Registration expiry Date

14th Jan 2031

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

MELAGENIX

Trademark usage description

pharmaceutical preparations in the form of pills and injections for the treatment of cancer mobile apps to facilitate patient communication with medi Read More

Classification Information


Class [005]
Pharmaceutical preparations in the form of pills and injections for the treatment of cancer


Classification kind code

11

Class [009]
Mobile apps to facilitate patient communication with medical doctors and medical laboratories in the field of lab test results


Classification kind code

11

Class [010]
Apparatus for carrying-out automated diagnostic tests of tumour preparations


Classification kind code

11

Class [016]
Brochures, leaflets, pamphlets


Classification kind code

11

Class [041]
Electronic publication of texts and printed matter, namely books and pamphlets, other than publicity texts, on the Internet; Publication of brochures, leaflets, pamphlets in electronic form; Publication of printed matter, namely brochures, leaflets, pamphlets; Publication of instructional literature with respect to medical diagnosis


Classification kind code

11

Class [042]
Chemical laboratories; Scientific laboratory services for the analysis of blood and tissue samples taken from patients; Analytical laboratory services for the analysis of blood and tissue samples taken from patients


Classification kind code

11

Class [044]
Medical laboratory services for the analysis of samples taken from patients; Medical diagnostic services; Medical with respect to cancer staging, prognosis, and treatment in printed and electronic form; Advisory services relating medical problems with respect to cancer and cancer treatment; Advisory services relating to medical services with respect to cancer and cancer treatment; Medical screening; Genetic testing for medical purposes; Preparation of reports relating to medical matters; Medical examination of individuals (Provision of reports relating to the -); Performing diagnosis of diseases; Providing medical information in the field of dermatology; Genetic counseling; Providing medical advice in the field of dermatology; Pharmaceutical services; Analysis of human tissues for medical treatment


Classification kind code

11

Mark Details


Serial Number

1886605

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 24th Jun 2020
Advertised
Submitted for opposition 26
on 5th Jun 2020
Approved
Submitted for opposition 27
on 5th Jun 2020
Approval Notice Sent
Submitted for opposition 15
on 13th Mar 2020
Correspondence Created
Submitted for opposition 22
on 25th Jul 2019
Search Recorded
Submitted for opposition 20
on 25th Jul 2019
Examiner's First Report
Submitted for opposition 135
on 7th Dec 2018
Amendment to Application
Submitted for opposition 31
on 13th Mar 2018
Formalized
Submitted for opposition 30
on 7th Mar 2018
Filed
Submitted for opposition 1
on 7th Mar 2018
Created